Peng Liu
- Filtration and Separation top 5%
- Hematology top 5%
- Multiple Myeloma Research and Treatments 39
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 26
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Oncology top 10%
- Peptidase Inhibition and Analysis 12
- Rehabilitation top 10%
-
- Lymphoma Diagnosis and Treatment 20
- Cancer Mechanisms and Therapy 10
-
- Protein Degradation and Inhibitors 17
- Amyloidosis: Diagnosis, Treatment, Outcomes 9
- Co-authors
- Jing LiJiadai XuKun‐Liang GuanJian DongZheng WeiYiping SunYue XiongLibo Jiang
- Journals
- Advanced Materials (1 paper)Journal of Clinical Investigation (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Peng Liu
128 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 109
- Filtration and Separation 52
- Hematology 221
- Genetics 126
- Oncology 291
- Rehabilitation 70
Countries citing papers authored by Peng Liu
This map shows the geographic impact of Peng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Liu more than expected).
Fields of papers citing papers by Peng Liu
This network shows the impact of papers produced by Peng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Liu. The network helps show where Peng Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peng Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 17 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 1 | |
| 13 | Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition | 2020 | 1 |
| 14 | 2020 | 5 | |
| 15 | 2020 | 19 | |
| 16 | 2020 | 8 | |
| 17 | 2020 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2011 | 13 | |
| 20 | 2010 | 2 |
About Peng Liu
Peng Liu is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 143 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (39 papers), Chronic Lymphocytic Leukemia Research (26 papers), Lymphoma Diagnosis and Treatment (20 papers), Protein Degradation and Inhibitors (17 papers), Peptidase Inhibition and Analysis (12 papers), Cancer Mechanisms and Therapy (10 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). The work is most often cited by research in Filtration and Separation (52 citations), Hematology (221 citations) and Genetics (126 citations). Peng Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jing Li, Jiadai Xu, Kun‐Liang Guan, Jian Dong, Zheng Wei, Yiping Sun, Yue Xiong, Libo Jiang, Houlei Wang and Hai‐Xin Yuan. Their work appears in journals such as Advanced Materials, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.